Skip to content

Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations

Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06935513
Acronym
AISP
Enrollment
300
Registered
2025-04-20
Start date
2025-04-20
Completion date
2026-04-20
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Diabetes, Dyslipidemia, Hypertension, Obesity and Overweight, Physical Inactivity, Smoking

Brief summary

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

Detailed description

A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.

Interventions

BEHAVIORALWearable Devices

Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.

Sponsors

Affiliated Hospital of Nantong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with hypertension; 2. Diagnosed with diabetes; 3. Diagnosed with atrial fibrillation; 4. Smoking subjects; 5. Physical inactive subjects; 6. Obesity and overweight subjects; 7. Must be able to use smart wearable devices.

Exclusion criteria

1. Diagnosed with malignancies; 2. Diagnosed with psychiatric disorders; 3. Diagnosed with cognitive impairment; 4. Unable to operate smart wearable devices.

Design outcomes

Primary

MeasureTime frameDescription
medication adherence and risk factor control rates6 months1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.

Secondary

MeasureTime frameDescription
incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events6 monthsStroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.

Countries

China

Contacts

Primary ContactQiuhong Ji, MD, PhD
jiqiuhong@ntu.edu.cn+8613962916293
Backup ContactPengyu Gong, MD
gongpengyu@ntu.edu.cn+8615720800870

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026